Navigation Links
Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Company's Anthrax Therapeutic
Date:9/25/2007

with or without an antibiotic."

Anthim(TM) Background

Anthim is high affinity monoclonal antibody that targets the protective antigen component of anthrax infection, blocking the bacteria's ability to form deadly toxins. It is being developed for prophylaxis and post-exposure treatment of inhalation anthrax. Anthim has been granted Fast Track status and Orphan Drug Designation by the FDA and is being developed under the FDA Animal Rule, a regulatory process specifically designed for the development of medical countermeasures to bioterror threats. In April of 2007, Anthim was selected to R&D Directions' list of "100 Great Investigational Drugs.

About Elusys' Heteropolymer Antibody(TM) Technology

HP Antibodies represent a new approach for the treatment of antibiotic resistant infections distinct from traditional therapies. HP Antibodies utilize natural immune system mechanisms to clear pathogens and provide a means to develop novel drug candidates targeted against bacterial, viral and fungal infections. By targeting a unique immune receptor, HP Antibodies enhance a natural clearance mechanism and direct the rapid removal of pathogens from the circulation to tissue macrophages. Elusys is currently working on novel approaches to the treatment of Staphylococcus and Candida infections using HP antibodies.

About Elusys

Elusys is a privately held biopharmaceutical company focused on the development of antibody-based therapeutics for the treatment of life- threatening infectious disease. Current venture investors include Essex Woodlands Health Ventures LLC, Invesco Private Capital, Crescendo Ventures, MedImmune Ventures and Pfizer. For more information please visit http://www.elusys.com.


'/>"/>
SOURCE Elusys Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pelosi: Bush Veto of Stem Cell Bill Says No to the Hopes of Million of Families Across America
2. Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million Annually
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
5. Phase III Clinical Trial with 4-Month Long-Acting Formulation of Triptorelin: Ipsen Decides Not to Perform Further Administration
6. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
7. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
8. Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical Trial Data
9. MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines
10. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
11. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 2014 Extensiv hydrolysierte ... von Kuhmilchverträglichkeit     Kuhmilchproteinallergie (KMPA) ist ... und Kleinkindern. Der bisher übliche Umgang mit ... Babys bzw. deren stillenden Mütter Milchproteine zu ... bei einer beträchtlichen Anzahl von Kindern der ...
(Date:10/30/2014)... , Oct. 29, 2014 nebulizer is ... disorders (asthma, COPD and cystic fibrosis) that converts liquid ... easily reach into the lungs of a patient when ... global nebulizers market is dominated by various devices powered ... increasing prevalence of asthma, COPD and cystic fibrosis and ...
(Date:10/30/2014)... , Oct. 29, 2014 Hospital ... from one location to another, inside or outside ... transportation, hospital stretchers are also used for several ... and diagnostic and emergency platforms. The ... as well as future market potential of hospital ...
Breaking Medicine Technology:Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 2Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 3Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 3Hospital Stretchers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2Hospital Stretchers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 3
... 8, 2012 Reprints Desk, Inc., a Derycz Scientific ... of its new mobile-web application Article Viewer ... product websites, and portals for healthcare professionals (HCPs) ... use by companies in Pharmaceuticals, Biotechnology, Medical Devices and ...
... RALEIGH-DURHAM, N.C., May 8, 2012 Synteract, Inc ... a corporate sponsor and have two senior level directors ... inaugural Outsourcing in Clinical Trials Southeast conference ... May 15-16, 2012. Barbara Conley, associate director of clinical ...
Cached Medicine Technology:Medical Reprints Deployment on iPads and Websites Made Easier with New ePrints Mobile-Web App from Reprints Desk 2Medical Reprints Deployment on iPads and Websites Made Easier with New ePrints Mobile-Web App from Reprints Desk 3Synteract Sponsoring and Presenting at Outsourcing in Clinical Trials Southeast Conference 2Synteract Sponsoring and Presenting at Outsourcing in Clinical Trials Southeast Conference 3
(Date:10/31/2014)... available in French . ... is common but fantasizing about golden showers is not. ... project that scientifically defines sexual deviation for the first ... universitaire en santé mentale de Montréal and Institut Philippe-Pinel ... theories about deviant sexual fantasies incorporate the concept of ...
(Date:10/30/2014)... group at the DFG Research Center for Regenerative Therapies ... (CRTD) demonstrated for the first time the in vitro ... dimensions from mouse embryonic stem cells. Correct spatial organization ... dorsal/ventral axis was observed., This study has been published ... Reports " on 30.10.2014 ., For many years Elly ...
(Date:10/30/2014)... Don Allred Insurance, a leading provider of ... North Carolina residents, is excited to announce the Grand ... Mall. The new branch has been up and running ... all facets of the insurance selection process from quote ... Allred couldn’t be happier with the timing of this ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Radio listeners ... raising questions about the impact of traditional radio commercials ... method most likely to influence a purchasing decision. , ... of 525 consumers conducted by radio marketing company CRN ... categories, isolating the results of respondents who indicated they ...
(Date:10/30/2014)... Dr. Joseph Furlin MD, a certified obstetrician ... practices; OB GYN in Melrose Park, IL and ... contains important information about each of the care services and ... forms in English and Spanish. The navigation of the ... the website provide Dr. Furlin’s patients with important information regarding ...
Breaking Medicine News(10 mins):Health News:Sexual fantasies: Are you normal? 2Health News:Sexual fantasies: Are you normal? 3Health News:Reconstruction of a patterned piece of spinal cord in 3-D culture 2Health News:Allred Insurance Satellite Office Grand Opening 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 3Health News:Dr. Joseph Furlin Launches New Website with Information about Care Services 2
... Team Cojo to fight PKD, LOS ANGELES, ... transplant, fashion critic and Entertainment Tonight correspondent,Steven "Cojo" ... million people,worldwide affected by Polycystic Kidney Disease (PKD)., ... common, life-threatening genetic,diseases, affecting more people than Down ...
... American Journal of Nursing (AJN) announced today ... Award is being given to Jean and Ric Edelman, ... generosity to nursing. The Award, recognizing individuals or ... and excellence in nursing practice, was presented on October ...
... Greater ... Flexibility, PITTSBURGH, ... that assist individuals with,significant speech, language and learning disabilities, announced the,release ... new release includes a range of new features that enhance,communication options, ...
... change as culprits , , WEDNESDAY, Oct. 29 (HealthDay News) ... infectious diseases, and that number could increase dramatically during ... delivered in a report, Germs Go Global: Why ... released Wednesday by the Trust for America,s Health (TFAH). ...
... researcher and director of the Institute for Cardiovascular Regeneration ... Advanced Grant, from the European Research Council to support ... will be investigating how to improve the healing process ... the repair of heart tissue. This research application is ...
... WASHINGTON, Oct. 29 CAQH, a nonprofit alliance ... healthcare,administration, announced today that the American Medical Association ... Information Exchange,(CORE) initiative., Joseph M. Heyman, MD, ... the,following statement of support for CORE: "The standardized ...
Cached Medicine News:Health News:Cojo to Hit the Streets of LA for 2008 Walk for PKD 2Health News:The American Journal of Nursing honors Jean and Ric Edelman 2Health News:The American Journal of Nursing honors Jean and Ric Edelman 3Health News:DynaVox Releases Software Version 1.05 for DynaVox V and Vmax 2Health News:DynaVox Releases Software Version 1.05 for DynaVox V and Vmax 3Health News:Threat From Infectious Diseases Growing 2Health News:Threat From Infectious Diseases Growing 3Health News:Promoting the healing process after a heart attack 2Health News:American Medical Association Endorses CAQH CORE Effort to Standardize and Streamline Patient Administrative Data Exchange 2
... Cement consists of a two ... bone cement liquid within a ... polyethylene bag,containing bone cement powder ... interiors of the blister pack,and ...
... Radiopaque Bone Cement consists of ... sterile,ampule containing bone cement liquid ... a sterile polyethylene bag,containing bone ... pouch. The interiors of the ...
A "doughy" type of bone cement intended for manual application....
... technology, such as a recessed scratch-resistant sapphire ... housings, this arthroscope has superior clarity and ... Steris and steam autoclaving or soaked in ... to fit ACMI, Wolf, Dyonics and Storz ...
Medicine Products: